I continue to support the recommendation of the Health Committee that the Bill, in its current form, should not proceed to Committee Stage, and the recommendations of the Health Products Regulatory Authority (HPRA) that access to cannabis, if permitted for medical purposes, should only be initiated under the direct supervision of an appropriate medical consultant, as part of a clearly defined monitored access programme.
Pending full operation of the upcoming Medical Cannabis Access Programme, doctors continue to utilise the Ministerial licencing route to prescribe medical cannabis for their patients. Licences have now been granted for twelve individual patients, the majority of whom are obtaining their medical cannabis from a Dutch pharmacy on foot of their medical prescription.